Eli Lilly lowers insulin costs as coronavirus crisis deepens

Drugmaker Eli Lilly & Co said on Tuesday it has capped the out-of-pocket cost for insulin to $35 per month to help diabetes patients across the United States, many of whom are facing financial difficulties due to the coronavirus outbreak.

from Reuters: U.S. https://ift.tt/39QngbI